|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| A61K 31/4439 | (2013.01) | ||
| C07D 207/12 | (2006.01) | ||
| C07C 309/66 | (2013.01) | ||
| C07C 309/66 | (2006.01) | ||
| C07D 207/12 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| C07D 401/12 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3510023 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17849479.5 |
| Date of filing the European patent application | 2017-09-06 | |
| (97) | Date of publication of the European application | 2019-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/050332 |
| Date | 2017-09-06 |
| (87) | Number | WO 2018/048943 |
| Date | 2018-03-15 |
| (30) | Number | Date | Country code |
| 201662384596 P | 2016-09-07 | US |
| (72) |
LONERGAN, David , US
HOLME, Kevin Ross , US
ROWBOTTOM, Martin W. , US
|
| (73) |
Pharmakea, Inc. ,
3030 Bunker Hill Street Suite 300, San Diego, California 92109,
US
|
| (54) | CRYSTALLINE FORMS OF A LYSYL OXIDASE-LIKE 2 INHIBITOR AND METHODS OF MAKING |
| CRYSTALLINE FORMS OF A LYSYL OXIDASE-LIKE 2 INHIBITOR AND METHODS OF MAKING |